PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50325F80038Amoxicillin trihydrate 500 MG ORAL capsules — Altitude Technologies Inc

Altitude Technologies Inc holds $17.5M across 2,826 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent 36F79725D0059. Competition previously drew 3 offers. Set-aside status: SBA. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Aspr/Orm-Sns

Awarding office

Altitude Technologies Inc

Recipient

Sep 29, 2027

PoP end

$47.8M

Obligated

325412

NAICS

6505

PSC

SBA

Set-aside

3 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Altitude Technologies Inc — $90

Contract facts

SBA

Contract number75A50325F80038

Also listed as36F79725D0059-75A50325F80038

AgencyAspr/Orm-Sns

Awarding officeAspr/Orm-Sns

IncumbentAltitude Technologies Inc

UEIL6NXD48QG5M1

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79725D0059

Place of performanceTULSA, OK

PoP end (current)Sep 29, 2027

PoP end (w/ options)Sep 29, 2029

Obligated$47.8M

AMOXICILLIN TRIHYDRATE 500 MG ORAL CAPSULES 60 AND 100 COUNT BOTTLES is a federal SBA award for Aspr/Orm-Sns held by Altitude Technologies Inc. Estimated value $47.8M ($47.8M obligated). Current period of performance ends Sep 29, 2027 (potential Sep 29, 2029). Last award drew 3 bidders. Place of performance: TULSA, OK.

AMOXICILLIN TRIHYDRATE 500 MG ORAL CAPSULES 60 AND 100 COUNT BOTTLES

Recompete timing

Public

● Expiring in 405 days

Current PoP ends Sep 29, 2027 (405 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Altitude Technologies Inc — $17.5M obligated across 2,826 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($17.5M) · all agencies

Department of Defense (DOD)$9.7M · 55%Department of Justice (DOJ)$3.8M · 22%Department of Homeland Security (DHS)$2.3M · 13%Department of Health and Human Services (HHS)$1.6M · 9%

Open full company profile →

Related awards

Same parent · incumbent

15F06726F0000837

INDIVIDUAL FIRST AID KIT (IFAK)

$107K

Sep 18, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50325F80038?

75A50325F80038 (Amoxicillin trihydrate 500 MG ORAL capsules) is a Aspr/Orm-Sns award with an estimated value of $47.8M, currently held by Altitude Technologies Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50325F80038?

Aspr/Orm-Sns awarded 75A50325F80038 to Altitude Technologies Inc.

Who is the incumbent on 75A50325F80038?

Altitude Technologies Inc is the incumbent with $17.5M across 2826 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does Altitude Technologies Inc’s 75A50325F80038 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Sep 27, 2025